Abstract
Pulmonary mycetomas often occur in fibrocystic sarcoidosis. When this condition is complicated by hemoptysis, definitive surgery is usually precluded because of poor lung function. Intracavitary antifungal therapy has been described for the treatment of symptomatic pulmonary mycetomas. We report the first use of intracavitary voriconazole in the management of a Pseudallescheria angusta pulmonary mycetoma complicated by hemoptysis in a patient with fibrocystic sarcoidosis and renal transplant.
MeSH terms
-
Aged
-
Antifungal Agents / administration & dosage*
-
Hemoptysis / diagnosis*
-
Hemoptysis / drug therapy
-
Hemoptysis / microbiology
-
Humans
-
Immunocompromised Host
-
Kidney Transplantation
-
Lung Diseases, Fungal / complications
-
Lung Diseases, Fungal / diagnosis*
-
Lung Diseases, Fungal / drug therapy
-
Lung Diseases, Fungal / microbiology
-
Male
-
Mycetoma / complications
-
Mycetoma / diagnosis*
-
Mycetoma / drug therapy
-
Mycetoma / microbiology
-
Pseudallescheria / isolation & purification*
-
Pyrimidines / administration & dosage*
-
Sarcoidosis / complications*
-
Triazoles / administration & dosage*
-
Voriconazole
Substances
-
Antifungal Agents
-
Pyrimidines
-
Triazoles
-
Voriconazole